Telemedicine for Pediatric Emergency Care
Trial Summary
What is the purpose of this trial?
Teleconsultation, or the use of video telecommunications technology to deliver expert recommendations for care remotely, has been used to improve the safety and quality of emergency care for children in hospital-based acute care settings by providing real-time access to remote pediatric physician experts. Whether extending teleconsultation as a patient safety intervention to emergency medical systems (EMS) outside hospitals can similarly benefit sick and injured children in the community is unknown. Advances in mobile technology have made teleconsultation more accessible and affordable for EMS systems. However, this intervention has been underutilized by EMS partially due to the lack of prehospital research supporting its efficacy for pediatric applications. In prior simulation studies, the investigators found high intervention acceptance among key stakeholder groups (pediatric emergency physicians and paramedics), and demonstrated that it was feasible to integrate video communication into prehospital clinical workflows involving critical care delivery in high-risk pediatric scenarios. These initial simulation studies were conducted in a controlled prehospital setting in static ambulances using infant simulator manikins to minimize risk to children and providers. Demonstrating feasibility and acceptability with real children in moving ambulances is the next step to build the necessary evidence base to support future planned prehospital efficacy trials with children. The investigators hypothesize that remote respiratory assessment of children by medical control physicians (expert physicians) using a mobile teleconsultation platform is acceptable to users (physicians and transport providers), and technically feasible in real transports.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Teleconsultation in the clinical trial Telemedicine for Pediatric Emergency Care?
Is telemedicine safe for pediatric emergency care?
Research suggests that telemedicine in pediatric emergency care is generally safe, but there are concerns about accurately assessing the urgency of a child's condition remotely. Studies have focused on ensuring that medical diagnoses and decisions made through telemedicine are appropriate and reasonable.13678
How is telemedicine unique for pediatric emergency care?
Telemedicine for pediatric emergency care is unique because it allows children in underserved areas to access specialized medical care without needing to travel to a children's hospital. This approach can help reduce disparities in healthcare access and improve the quality of care for critically ill pediatric patients.1891011
Research Team
Tehnaz Boyle, MD PhD
Principal Investigator
Boston Medical Center
Eligibility Criteria
This trial is for children in New England with respiratory illnesses who are stable enough for transport by Boston Children's Hospital. They must need things like extra oxygen, medications, or be stable on a ventilator. Kids can't join if their parents don't speak English, they have non-respiratory issues, or are too sick and might need emergency care during the ride.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Teleconsultation
Transport providers initiate a video-call from the ambulance to a medical control physician for remote respiratory assessment of children
Follow-up
Participants are monitored for acceptability and feasibility of the teleconsultation platform using a validated questionnaire
Treatment Details
Interventions
- Teleconsultation (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston Medical Center
Lead Sponsor
Dr. Alastair Bell
Boston Medical Center
Chief Executive Officer since 2023
MD from University of Oxford, MBA from Harvard Business School
Dr. Ravin Davidoff
Boston Medical Center
Chief Medical Officer since 2008
M.B., B.Ch. from University of Witwatersrand, South Africa
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Dr. Gary H. Gibbons
National Heart, Lung, and Blood Institute (NHLBI)
Chief Executive Officer since 2012
MD from Harvard Medical School
Dr. James P. Kiley
National Heart, Lung, and Blood Institute (NHLBI)
Chief Medical Officer since 2011
MD from University of California, San Francisco